StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
5297
This month
75
This week
23
This year
439
Today
4
Yesterday
11
Publishing Date
2024 - 04 - 19
1
2024 - 04 - 18
3
2024 - 04 - 17
7
2024 - 04 - 16
5
2024 - 04 - 15
7
Sector
Communications
1
Electronic technology
1
Health technology
14
Industrial services
1
Manufacturing
1
N/a
3
Producer manufacturing
1
Technology services
1
Utilities
1
Wholesale trade
1
Tags
Acquisition
16
Agreement
30
Biopharma
22
Business
29
Cancer
12
Ceo
12
Commercial
17
Company
20
Conference
144
Contract
12
Corporation
44
Day
13
Deadline
16
Earnings
16
Energy
35
Expansion
15
Financial
176
First
303
For
287
Global
29
Group
49
Growth
47
Health
16
International
23
Key
46
Life
12
Management
16
Market
127
Medical
19
Meeting
46
Million
58
N/a
1408
Nasdaq
13
Offering
38
One
36
Partnership
12
Pharmaceuticals
29
Platform
17
Positive
13
Presentation
18
Program
24
Reach
25
Report
119
Research
34
Results
261
Revenue
17
Sales
15
Security
12
Service
16
Services
27
Set
49
Solutions
26
Study
21
System
12
Technology
27
Therapeutics
54
Treatment
23
Trial
31
Update
31
Year
69
Entities
Abvc biopharma inc
1
Astellas pharma inc
1
Bridgebio pharma, inc.
1
California water service group holding
1
Clearmind medicine inc.
1
Clene inc
1
Diamedica therapeutics inc.
1
Eagle pharmaceuticals, inc.
2
Euro tech holdings company limited
1
Evoqua water technologies corp.
1
Genetic technologies ltd
1
Glaxosmithkline plc
1
Johnson & johnson
2
Koninklijke philips n.v.
1
Lexeo therapeutics, inc.
1
Mirum pharmaceuticals, inc.
1
Moleculin biotech, inc.
1
Neurobo pharmaceuticals, inc.
1
Novartis ag
1
Oncternal therapeutics, inc.
1
Orange
1
Sage therapeutics, inc.
1
Sanofi
2
Takeda pharmaceutical company limited
1
Teva pharmaceutical industries ltd
1
The9 limited
1
Ultragenyx pharmaceutical inc.
1
Verona pharma plc
1
Viatris inc.
1
Xylem inc.
1
Zevra therapeutics, inc.
1
Symbols
ABVC
1
ALPMF
1
ALPMY
1
AQUA
1
BBIO
1
CLNN
1
CLWT
1
CMND
1
CWT
1
DMAC
1
EGRX
2
FNCTF
1
GENE
1
GLAXF
1
GNTLF
1
GSK
1
JNJ
2
LXEO
1
MBRX
1
MIRM
1
NCTY
1
NRBO
1
NVS
1
NVSEF
1
ONCT
1
PHG
1
RARE
1
SAGE
1
SNY
2
SNYNF
2
TAK
1
TEVJF
1
VRNA
1
VTRS
1
XYL
1
ZVRA
1
Exchanges
Nasdaq
20
Nyse
6
Crawled Date
2024 - 04 - 19
1
2024 - 04 - 18
3
2024 - 04 - 17
7
2024 - 04 - 16
5
2024 - 04 - 15
7
Crawled Time
02:00
1
09:00
1
10:00
1
11:00
3
12:00
5
13:00
3
14:00
1
16:00
1
19:00
1
20:00
2
21:00
2
22:00
1
23:00
1
Source
www.biospace.com
5
www.globenewswire.com
10
www.prnewswire.com
8
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
published :
This week
tags :
Treatment
save search
Progressive Familial Intrahepatic Cholestasis Treatment Market Projected to Reach $156.14 million by 2030 - Exclusive Report by 360iResearch
Published:
2024-04-19
(Crawled : 02:00)
- prnewswire.com
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
Email alert
Add to watchlist
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
MIRM
|
$23.6
-1.05%
-1.06%
400K
|
Health Technology
|
Email alert
Add to watchlist
report
million
reach
treatment
market
California Water Service Group Moving Forward to Install PFAS Treatment Despite CPUC Dismissal of Request to Track Capital Costs in Pre-Approved Memorandum Account
Published:
2024-04-18
(Crawled : 21:00)
- globenewswire.com
CWT
|
News
|
$44.9
1.65%
0.0%
340K
|
Utilities
|
Email alert
Add to watchlist
water
california
service
group
treatment
European Medicines Agency (EMA) Grants Orphan Drug Designation for Moleculin's Treatment of Acute Myeloid Leukemia (AML)
Published:
2024-04-18
(Crawled : 19:00)
- biospace.com/
MBRX
|
News
|
$4.59
7.24%
6.75%
50K
|
Health Technology
|
5.61%
|
O:
4.91%
H:
11.36%
C:
0.67%
drug
treatment
designation
for
grants
leukemia
Oncternal Announces First Patient Dosed in Fourth Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer
Published:
2024-04-18
(Crawled : 13:00)
- globenewswire.com
ONCT
|
News
|
$8.79
-1.79%
-1.82%
2.8K
|
Health Technology
|
Email alert
Add to watchlist
onct-534
first
cancer
treatment
for
study
DiaMedica Therapeutics Announces First Patient Dosed in Relaunch of its Pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic Stroke
Published:
2024-04-17
(Crawled : 22:00)
- biospace.com/
DMAC
|
$2.45
-5.77%
-6.12%
17K
|
Health Technology
|
4.43%
|
O:
4.43%
H:
0.0%
C:
0.0%
dm199
first
stroke
treatment
for
trial
therapeutics
ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M
Published:
2024-04-17
(Crawled : 13:00)
- globenewswire.com
ABVC
|
News
|
$0.9963
-2.32%
-2.38%
460K
|
Wholesale Trade
|
-10.71%
|
O:
2.68%
H:
3.48%
C:
-11.3%
treatment
biopharma
royalties
global
for
agreement
NeuroBo Pharmaceuticals Doses First Patient in Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity
Published:
2024-04-17
(Crawled : 12:00)
- prnewswire.com
NRBO
|
$3.425
-1.01%
-1.02%
23K
|
Health Technology
|
1.76%
|
O:
8.53%
H:
0.0%
C:
-6.23%
da-1726
obesity
first
treatment
pharmaceuticals
for
trial
New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
Published:
2024-04-17
(Crawled : 12:00)
- globenewswire.com
GENE
|
News
0 d
|
$2.36
-25.32%
-33.9%
88K
|
Health Technology
|
-23.03%
|
O:
3.47%
H:
0.0%
C:
-3.66%
precision
treatment
Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders
Published:
2024-04-17
(Crawled : 12:00)
- globenewswire.com
CMND
|
$1.2
0.84%
0.83%
35K
|
n/a
|
-0.82%
|
O:
-0.82%
H:
0.0%
C:
0.0%
disorders
treatment
for
agreement
Sage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s Disease
Published:
2024-04-17
(Crawled : 12:00)
- biospace.com/
SAGE
|
$13.03
3.66%
3.53%
1.8M
|
Health Technology
|
-17.57%
|
O:
-15.02%
H:
3.55%
C:
-3.01%
sage-718
disease
treatment
topline
parkinson’s
therapeutics
results
study
Prostate Cancer: Advancements in Prevention and Treatment Drive Global Market Growth
Published:
2024-04-17
(Crawled : 09:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
0.63%
|
O:
0.12%
H:
0.51%
C:
0.51%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-0.08%
|
O:
-0.04%
H:
0.28%
C:
-0.16%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-0.78%
|
O:
1.05%
H:
0.0%
C:
0.0%
treatment
global
growth
market
Fracking Water Treatment Market size to record USD 1.20 billion growth from 2023-2027, Adoption of supercritical carbon in fracking is one of the key market trends, Technavio
Published:
2024-04-16
(Crawled : 23:00)
- prnewswire.com
XYL
|
$127.16
0.75%
0.0%
1.1M
|
Producer Manufacturing
|
-1.39%
|
O:
0.38%
H:
0.0%
C:
-1.77%
water
one
treatment
key
growth
market
Evidence for Clene’s CNM-Au8® as a Treatment for Repair and Remyelination in Multiple Sclerosis Presented in the Emerging Science Session at the 2024 American Academy of Neurology Annual Meeting
Published:
2024-04-16
(Crawled : 20:00)
- globenewswire.com
CLNN
S
|
$0.3275
-3.56%
-3.69%
1.2M
|
|
Email alert
Add to watchlist
au8
neurology
sclerosis
treatment
for
meeting
Sentynl Therapeutics Receives MHRA Authorization of NULIBRY® (fosdenopterin) for Treatment of MoCD Type A in Great Britain
Published:
2024-04-16
(Crawled : 16:00)
- biospace.com/
BBIO
|
$24.98
0.0%
2M
|
Health Technology
|
-3.18%
|
O:
-1.47%
H:
2.05%
C:
-0.59%
nulibry
authorization
treatment
for
therapeutics
Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published:
2024-04-16
(Crawled : 14:00)
- prnewswire.com
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
-1.77%
|
O:
-0.53%
H:
0.0%
C:
-1.24%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-1.19%
|
O:
-1.46%
H:
0.0%
C:
0.0%
PHG
|
$19.98
-0.84%
0.0%
500K
|
Health Technology
|
-2.52%
|
O:
-1.21%
H:
0.0%
C:
0.0%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
-2.22%
|
O:
-1.19%
H:
0.52%
C:
-0.17%
VRNA
|
$16.1
-1.83%
-1.86%
490K
|
Health Technology
|
1.9%
|
O:
1.65%
H:
2.43%
C:
0.87%
reach
treatment
research
market
Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich’s Ataxia Cardiomyopathy
Published:
2024-04-16
(Crawled : 12:00)
- globenewswire.com
LXEO
|
$12.1
-1.31%
-1.32%
83K
|
|
2.81%
|
O:
5.32%
H:
0.0%
C:
-2.63%
lx2006
fda
candidate
granted
treatment
designation
for
therapeutics
therapy
Zevra Therapeutics Presents New Data on the Long-Term Safety and Efficacy of Arimoclomol as a Treatment for Niemann-Pick Disease Type C at the SIMD 45th Annual Meeting
Published:
2024-04-15
(Crawled : 21:00)
- globenewswire.com
ZVRA
|
$4.51
-2.8%
-2.88%
260K
|
n/a
|
-3.03%
|
O:
1.15%
H:
1.03%
C:
-1.45%
disease
treatment
for
meeting
therapeutics
Robbins Geller Rudman & Dowd LLP, Lieff Cabraser Heimann & Bernstein LLP, and Dugan Law Firm, APLC Announce a $78 Million Class Action Settlement for Third Party Payors That Paid or Reimbursed Costs for Prescription Opioids or Treatment Related to Opioid Misuse, Addiction, and/or Overdose
Published:
2024-04-15
(Crawled : 20:00)
- prnewswire.com
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-2.16%
|
O:
-2.09%
H:
0.0%
C:
0.0%
opioid
million
treatment
for
Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea & Vomiting at the Upcoming ASPAN 2024 National Conference in Orlando, Florida
Published:
2024-04-15
(Crawled : 13:00)
- biospace.com/
EGRX
|
$4.505
2.62%
2.55%
140K
|
Health Technology
|
-2.09%
|
O:
-8.14%
H:
19.55%
C:
18.18%
conference
treatment
pharmaceuticals
for
trial
response
Ultragenyx Announces Positive Interim Phase 1/2 Data in Patients with Angelman Syndrome After Treatment with GTX-102
Published:
2024-04-15
(Crawled : 11:00)
- globenewswire.com
RARE
F
|
$43.38
-1.65%
-1.68%
770K
|
Health Technology
|
-11.65%
|
O:
-10.79%
H:
0.0%
C:
-3.75%
gtx-102
positive
treatment
← Previous
1
2
Next →
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
News
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.